Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_assertion description "[Nineteen percent (19/100) of those with haemophilia A and 37% (6/16) with haemophilia B developed inhibitors at 12-18 mo of age, after exposure to FVIII/FIX concentrates for an average of 14 d in the case of haemophilia A and 16 d in haemophilia B.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_assertion evidence source_evidence_literature NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_assertion SIO_000772 12222714 NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_assertion wasDerivedFrom befree-20140225 NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_assertion wasGeneratedBy ECO_0000203 NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP418101.RAzxxZUNCF90Z3i7UeBk1NSj7hryTbjkoLTMcxBwBlxrI130_provenance.